Oral administration of repaglinide, between 0.5 to 4 mg twice to three times daily, to a maximum of 16 mg, produces glycemic control in a similar order to other antihyperglycemic agents. Repaglinide should be administered approximately 30 minutes before an intended meal, andÂ the dose skipped if a scheduled mealtime is skipped. Dose adjustments should be reviewed a minimum of one week later.